Deal Announcements

Complete Genomics Closes Series E Financing

Friday, August 20, 2010 5:37:00 AM PDT | VentureDeal Staff

Mountain View, California  --  Biotechnology company Complete Genomics secured $39 million in its fifth round of institutional venture capital investment.

Complete Genomics develops high performance DNA sequencing technologies to help reduce drug development research costs.

The investment syndicate was led by new investor Sands Capital Management. Investment proceeds purposes were not disclosed.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1